Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KRRO
#3223
Korro Bio, Inc. Common Stock
12.130
0
+4.39%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+4.39%
Monthly Change
+6.22%
6 month change
-68.82%
Year Change
-68.82%
Previous Close
11.620
0
Open
12.130
0
Bid
Ask
Low
12.130
0
High
12.130
0
Volume
27
Markets
US Stock Market
Healthcare
KRRO
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
9.37 M
9.39 M
9.39 M
9.39 M
9.42 M
—
Valuation ratios
Enterprise value
249.88 M
301.79 M
99.34 M
83.68 M
426.84 M
911.66 M
Price to earnings ratio
0.24
-4.06
-1.85
-1.28
-5.1
-12.29
Price to sales ratio
—
149.54
—
—
60.02
—
Price to cash flow ratio
1.68
5.65
2.56
1.73
6.54
16.48
Price to book ratio
0.06
0.49
0.06
0.04
0.15
0.74
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.09
0.12
0.14
0.11
0.46
Return on equity %
0.12
0.13
0.17
0.22
0.18
0.71
Return on invested capital %
-102.59
-71.83
-81.21
-127.88
-99.97
-380.89
Gross margin %
—
100
100
100
100
400
Operating margin %
—
-1 014.53
-981.18
-1 863.15
-1 764.86
-5 623.72
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
933.47
917.14
1 765.07
1 656.97
5 272.64
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
11.23
8.79
9.41
5.98
6.71
30.89
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0.01
0.01
0.01
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.83
0.84
2.61
2.05
1.83
7.32
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
15.62
6.24
12.25
10.27
9.85
38.6
Net current asset value per share
17.42
14.74
12.92
10.93
10.46
49.06
Tangible book value per share
76.43
77.72
76.61
79.53
81.65
315.52
Working capital per share
15.87
13.07
11.55
9.1
8.9
42.62
Book value per share
76.43
77.72
76.61
79.53
81.65
315.52
News
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?
Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential
Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment
Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential
Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28
William Blair reiterates Market Perform rating on Korro Bio stock
Raymond James reiterates Market Perform rating on Korro Bio stock
Cantor Fitzgerald upgrades Korro Bio stock to Overweight on UCD program
Korro Bio stock holds steady as Jones Trading reiterates Hold rating
Clear Street raises Korro Bio stock price target to $10 on new lead program